LP01™ + LPC00 (ALLERFLORA)
Ophthalmology
Allergic rhinitis
Reduces nasal symptoms
Improves severity of allergic rhinitis
Decreases need for corticosteroids and antihistamines
1) LP01 1 billion cells + LPC00 1 billion cells + FOS
Single strain
Blend
Finished dosage form
1) Manzotti G. et al. Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis. Journal of Contemporary Immunology, Vol. 1 No.2 pp. 67-80, 2014. DOI:10.7726/JCI.2014.1008
2) Fassio F. House dust mite-related respiratory allergies and probiotics: a narrative review. Clin Mol Allergy, 2018,16:15. DOI https://doi.org/10.1186/s12948-018-0092-9
Internal data on immunomodulation available upon request
a) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
b) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32. Doi: 10.1097/MCG.0b013e31826852b7
c) Amoruso A. et al. A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 2019; 7:214. Doi: 10.35248/2329-8901.19.7.214
